NetworkNewsBreaks

WednesdayApr 23, 2025 10:38 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Appoints Eric Poma as CEO to Lead Next Phase of Clinical Growth

Calidi Biotherapeutics (NYSE American: CLDI) announced the appointment of Eric Poma, Ph.D., as Chief Executive Officer and member of its Board of Directors, effective Apr. 22. He succeeds Allan Camaisa, who will continue as a Board member. Dr. Poma, a veteran biotech leader, brings over 30 years of experience, including roles at Molecular Templates (NASDAQ: MTEM), where he raised over $250 million and secured strategic partnerships with Takeda, Vertex, and BMS. As Calidi advances its systemic virotherapy platform and prepares for a dose-escalation trial of CLD-201 in solid tumors, the leadership change is expected to support the company’s transition into…

Continue Reading

WednesdayApr 23, 2025 10:24 am

NetworkNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Expands NY Pipeline With 4.584 MW Community Solar Project 

Disseminated on behalf of SolarBank Corporation  SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) announced plans to develop a 4.584 MW DC ground-mount solar project in upstate New York, known as the Forest Hill Rd project. The site lease is secured, and an interconnection study is in progress. Once completed, the project will operate as a community solar initiative and is eligible for New York's VDER rate mechanism and NYSERDA NY-Sun incentives. SolarBank emphasized its supply chain resilience, noting that its operations are unaffected by the U.S. tariff hikes on Southeast Asian solar imports. The company continues sourcing panels from…

Continue Reading

WednesdayApr 23, 2025 9:30 am

NetworkNewsBreaks – VERAXA Biotech AG and Voyager Acquisition Corp. (NASDAQ: VACH, “Voyager”) Announce $1.64 Billion Business Combination to Create Clinical-Stage Cancer Therapy Powerhouse 

VERAXA Biotech AG, a cancer therapy innovator, and proposed de-SPAC target of Voyager Acquisition Corp. (NASDAQ: VACH) announced a definitive agreement to merge in a transaction that would value the combined company at approximately $1.64 billion. Upon closing, VERAXA is expected to trade on NASDAQ under the ticker symbol “VERX.” The company is advancing a proprietary Bi-Targeted Antibody Cytotoxicity (“BiTAC”) platform for dual-marker cancer therapeutics, including bispecific ADCs and T cell engagers, with a pipeline featuring nine programs and an active Phase 1 trial in leukemia. VERAXA is backed by majority shareholders Xlife Sciences AG (SIX: XLS), EMBL and EMBLEM,…

Continue Reading

WednesdayApr 23, 2025 9:25 am

NetworkNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Partners with Davis Polk to Launch MAGA-Themed Crypto ETFs 

Trump Media & Technology Group (NASDAQ: DJT) the parent company of Truth Social, has announced a partnership with prestigious law firm Davis Polk & Wardwell to develop MAGA-themed cryptocurrency exchange-traded funds (ETFs). This collaboration includes Crypto.com and Yorkville America Digital, aiming to launch ETFs focused on digital assets and "Made in America" industries. Notably, Davis Polk's Greg Andres, who co-leads its white-collar defense practice, previously served on Special Counsel Robert Mueller's team during the investigation into Russian interference in the 2016 election. The partnership signifies a significant move by a major law firm to engage with Trump despite his history…

Continue Reading

WednesdayApr 23, 2025 9:10 am

NetworkNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Updates 2025 Exploration Plans for Storm Copper Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) provided an update on the 2025 exploration program at the Storm Copper Project in Nunavut, operated by American West Metals under a 20/80 joint venture. The upcoming program will focus on the >20km Midway-Storm-Tornado corridor, targeting high-priority prospects including Midway, Tornado, and Blizzard, all showing visual copper sulfide mineralization in brecciated dolomites of the Allen Bay Formation. Historic drill holes, previously unsampled, will be assayed in 2025. Large-scale geophysical anomalies and a planned Mobile Magneto-Telluric survey aim to refine targets and identify deeper copper deposits across the 110km strike length. A Preliminary Economic Assessment is…

Continue Reading

TuesdayApr 22, 2025 3:53 pm

NetworkNewsBreaks – Splash Beverage Group Inc. (NYSE American: SBEV) Responds to Unusual Trading Activity Amid NYSE Appeal Process 

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, announced unusually high trading activity as it enters the appeal process with the NYSE regarding its listing status. The company indicated that, to its knowledge, there have been no new material developments since its last announcement regarding its potential merger/acquisition with Western Son Vodka, believing the unusual market action is due in part to algorithmic trading and short selling activities. Splash will enter the appeal process with the NYSE Listing Qualifications Panel and continue trading its common stock and warrants during this period. The company remains confident…

Continue Reading

TuesdayApr 22, 2025 3:32 pm

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Faces Mixed Outlook Ahead of Q1 Earnings 

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is set to report its first-quarter 2025 earnings on April 24, with analysts projecting earnings of $2.01 per share and revenues of $75.53 billion. The company’s advancements in generative AI, particularly through its Gemini platform, have bolstered its search and cloud services. However, concerns about high valuation and intense competition in the cloud sector contribute to a cautious investor sentiment.  As of 1:08 p.m. EDT on April 22, 2025, Alphabet's stock is trading at $151.61, up $3.94 (2.67%) from the previous close.  To view the full article, visit https://nnw.fm/QdroW  About Alphabet Inc.  Alphabet Inc. is…

Continue Reading

TuesdayApr 22, 2025 3:20 pm

NetworkNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Launches Edits App to Empower Creators 

Meta Platforms (NASDAQ: META) has officially launched Edits, a standalone mobile video creation app designed to help creators produce high-quality content, including Instagram Reels, directly from their phones. The free app offers long-form capture, clip-level editing, real-time insights, and seamless integration with Instagram and Facebook.   As of 1:14 p.m. EDT on April 22, 2025, Meta's stock is trading at $505.66, up $21.00 (4.33%) from the previous close.   To view the full article, visit https://nnw.fm/j3gDg  About Meta Platforms Inc.  Meta Platforms Inc. is a leading technology company that builds innovative products and services to connect people and communities. The company's offerings…

Continue Reading

TuesdayApr 22, 2025 3:12 pm

NetworkNewsBreaks – NVIDIA Corp. (NASDAQ: NVDA) Rises as Market Rebounds and Analysts Maintain Optimism 

NVIDIA (NASDAQ: NVDA) shares are climbing today, buoyed by a broader market recovery and continued analyst support. After a sharp decline on Monday, prompted by President Donald Trump's criticism of Federal Reserve Chair Jerome Powell and concerns over interest rate policies, the market is rebounding. Nvidia, having dropped approximately 4.8% in the previous session due to reports of potential delays in upcoming chip releases, is now benefiting from renewed investor confidence. Analysts at Barclays and Bank of America have both lowered their price targets for Nvidia but maintained buy-equivalent ratings, citing the company's strong earnings potential despite geopolitical challenges. ​  …

Continue Reading

TuesdayApr 22, 2025 3:10 pm

NetworkNewsBreaks – BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB), SpayVac-for-Wildlife Inc. Expand License Agreement

BioVaxys (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB) and SpayVac-for-Wildlife announced an expansion of the fields of use in the current license agreement to include commercial aquaculture and the farm-raised fish market. With this expansion, SpayVac’s markets now include its no-booster fertility-control vaccines for aquaculture and overabundant feral/wild/invasive and select production and companion animals, which significantly increases its global revenue potential. “This presents a substantial addressable market for SpayVac’s contraceptive vaccines, which are being developed as an alternative to triploidy—a form of genetic manipulation commonly used in aquaculture to induce sterility,” said SpayVac-for-Wildlife CEO Thomas D’Orazio. “With only a single dose…

Continue Reading